Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease | Scientific Reports
ACE inhibitors: The secret to prevent cirrhosis complications and HCC in NAFLD?
Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data | PLOS ONE
JCM | Free Full-Text | Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options
Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study
The Korean Journal of Internal Medicine
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research
Life | Free Full-Text | Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury
Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis. | Semantic Scholar
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020 | SpringerLink
Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease,Hepatology - X-MOL
Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study
Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week | Journal of the American College of Cardiology
PDF) Liver disease and the renin-angiotensin system: Recent discoveries and clinical implications
Prescribing Medications in Patients with Decompensated Liver Cirrhosis
Liver cirrhosis - The Lancet
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020 | SpringerLink
Renin angiotensin system in liver diseases: Friend or foe?
![PDF] Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ad2de68f5ba5bdeae21e8d6eb7c8c50c69b33a93/3-Figure1-1.png "PDF] Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study | Semantic Scholar")
PDF] Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study | Semantic Scholar
ACE Inhibitors: Drug List, Side Effects, Mechanism of Action, Example Medications, Contraindications — EZmed
Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients
JCM | Free Full-Text | Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options
